Vireo Growth Inc. 8-K

What Happened

• Vireo Growth Inc.’s subsidiary Vireo Health of Arcadia, LLC entered a Purchase Agreement on July 19, 2026 with Columbia Care LLC, The Cannabist Company Holdings Inc. and certain affiliates to buy equity interests and assets used in cannabis businesses in Colorado, Illinois, Massachusetts, New Jersey and West Virginia. A press release announcing the transaction was issued July 20, 2026.
• The deal is being implemented subject to approval by the Ontario Superior Court (a Sale Order) because Cannabist and an affiliate are debtors in a Canadian CCAA proceeding, and is contingent on required U.S. state cannabis regulatory approvals and other customary closing conditions.

Key Details

• Consideration: up to approximately $18.75 million in cash paid at one or more market closings, plus up to approximately $16.25 million in seller financings under loan and security agreements (total consideration ≈ $35.0M composed of cash + seller loans).
• Timing: Closings will occur on a Market-by-Market basis through 2026 and into 2027 as conditions are satisfied or waived; parties may terminate if a Market closing does not occur by July 19, 2027 subject to limits.
• Security and protections: Seller financing will be secured by liens on certain assets/equity; agreements include mechanisms for post-closing price adjustments, minimum cash levels at dispensaries, replacement/assumption of guarantees/letters of credit, and indemnities with set-off rights against loan amounts.
• Conditions and risks: Consummation requires the Canadian court Sale Order, state-level license/permit transfers or approvals, accuracy of reps and warranties, performance of covenants, absence of material adverse effects, and certain Market-specific conditions (e.g., dispute resolution and reorganization steps in New Jersey; Columbia Care has certain unilateral termination rights related to some Massachusetts medical licenses).

Why It Matters

• This is a material acquisition for Vireo’s U.S. retail footprint: it would add operations and assets across five states, subject to regulatory approvals and court supervision of the Canadian seller’s restructuring.
• The structure uses meaningful seller financing, which reduces upfront cash required but creates secured debt obligations and linkage between purchase price and post-closing adjustments. Investors should watch regulatory approvals, the Canadian court Sale Order, the market-by-market closing schedule, and any contingent liabilities or license transfer issues that could affect timing, cash flows, or leverage.